IFG
CTNM

Independent Financial Group’s Contineum Therapeutics CTNM Stock Holding History

Independent Financial Group’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$443K Hold
27,021
– – 0.01% 1046
2026
Q1 		$353K Hold
27,021
– – 0.01% 1086
2025
Q4 		$309K Hold
27,021
– – 0.01% 1135
2025
Q3 		$317K Hold
27,021
– – 0.01% 1067
2025
Q2 		$107K Buy
+27,021
New +$117K ﹤0.01% 1264

Other funds holding CTNM

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Independent Financial Group's CTNM Position: Q2 2026 in Review

Independent Financial Group held its Contineum Therapeutics (CTNM) position steady in Q2 2026 at 27,021 shares worth $443K. The position accounts for 0.01% of the portfolio, ranked #1046.

Independent Financial Group first reported a position in CTNM in Q2 2025 and has held it in 5 quarters since. 102 funds tracked by Wall St. Rank hold CTNM as of Q2 2026.

  • Independent Financial Group held 27,021 shares of Contineum Therapeutics worth $443K as of Q2 2026.
  • Independent Financial Group left its Contineum Therapeutics share count unchanged in Q2 2026.
  • Contineum Therapeutics made up 0.01% of Independent Financial Group's portfolio in Q2 2026, its #1046 holding.
  • Independent Financial Group first reported a position in Contineum Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 102 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q2 2026.

Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.